Foresite Capital Management IV, LLC Diversified Active

CIK: 0001704132 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 16, 2021

Total Value ($000): $739,796 (100.0% shares, 0.0% debt)

Holdings (13)

— Kinnate Biopharma Inc. 30.4%

Value ($000) $225,156 Shares 9,671,643 Est. Cost $39.78 Unrealized —

— Lyell Immunopharma, Inc. 29.2%

Value ($000) $215,703 Shares 13,282,181 Est. Cost $16.24 Unrealized —

PHVS Pharvaris N.V. 8.2%

Value ($000) $60,770 Shares 3,261,926 Est. Cost $31.46 Unrealized -27.9%

ACRS Aclaris Therapeutics, Inc. 8.1%

Value ($000) $59,687 Shares 3,399,034 Est. Cost $15.18 Unrealized +49.7%

QSI Quantum-Si Incorporated 7.4%

Value ($000) $54,724 Shares 4,463,619 Est. Cost $10.48 Unrealized 0.0%

KURA Kura Oncology, Inc. 5.2%

Value ($000) $38,571 Shares 1,849,947 Est. Cost $20.39 Unrealized +21.8%

NRIX Nurix Therapeutics, Inc. 4.3%

Value ($000) $31,990 Shares 1,205,798 Est. Cost $25.20 Unrealized +16.5%

RLAY Relay Therapeutics, Inc. 2.8%

Value ($000) $20,358 Shares 556,380 Est. Cost $38.13 Unrealized -13.6%

CYTK Cytokinetics Incorporated 1.5%

Value ($000) $10,788 Shares 545,101 Est. Cost $8.72 Unrealized +169.2%

OLMA Olema Pharmaceuticals, Inc. 1.3%

Value ($000) $9,570 Shares 342,030 Est. Cost $46.89 Unrealized -39.3%

— Cymabay Therapeutics, Inc. 1.1%

Value ($000) $7,792 Shares 1,787,094 Est. Cost $3.49 Unrealized —

— Decibel Therapeutics, Inc. 0.3%

Value ($000) $2,560 Shares 297,711 Est. Cost $11.36 Unrealized —

— Tempest Therapeutics, Inc. 0.3%

Value ($000) $2,127 Shares 190,212 Est. Cost $11.18 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Kinnate Biopharma Inc.	9,671,643	$225,156	30.4%	$39.78	—	COM	49705R105
—	Lyell Immunopharma, Inc.	13,282,181	$215,703	29.2%	$16.24	—	COM	55083R104
PHVS	Pharvaris N.V.	3,261,926	$60,770	8.2%	$31.46	-27.9%	COM	N69605108
ACRS	Aclaris Therapeutics, Inc.	3,399,034	$59,687	8.1%	$15.18	+49.7%	COM	00461U105
QSI	Quantum-Si Incorporated	4,463,619	$54,724	7.4%	$10.48	0.0%	COM CL A	74765K105
KURA	Kura Oncology, Inc.	1,849,947	$38,571	5.2%	$20.39	+21.8%	COM	50127T109
NRIX	Nurix Therapeutics, Inc.	1,205,798	$31,990	4.3%	$25.20	+16.5%	COM	67080M103
RLAY	Relay Therapeutics, Inc.	556,380	$20,358	2.8%	$38.13	-13.6%	COM	75943R102
CYTK	Cytokinetics Incorporated	545,101	$10,788	1.5%	$8.72	+169.2%	COM	23282W605
OLMA	Olema Pharmaceuticals, Inc.	342,030	$9,570	1.3%	$46.89	-39.3%	COM	68062P106
—	Cymabay Therapeutics, Inc.	1,787,094	$7,792	1.1%	$3.49	—	COM	23257D103
—	Decibel Therapeutics, Inc.	297,711	$2,560	0.3%	$11.36	—	COM	24343R106
—	Tempest Therapeutics, Inc.	190,212	$2,127	0.3%	$11.18	—	COM	87978U108